Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related VECO
Benchmark Initiates Veeco Instruments At Buy
Benzinga's Top Initiations
Related UTHR
New Alzheimer's Trials Could Produce The Most Important Drugs In History
United Therapeutics Corporation Receives Paragraph IV Notice Letter for Tyvaso
United Therapeutics Misses on Q2 Earnings & Revenues - Analyst Blog (Zacks)

Analysts at B. Riley downgraded Veeco Instruments (NASDAQ: VECO) from “buy” to “neutral.” Veeco's shares closed at $30.55 yesterday. Veeco's trailing-twelve-month ROA is 5.44%.

Analysts at Goldman Sachs downgraded United Therapeutics (NASDAQ: UTHR) from “neutral” to “sell.” United Therapeutics' shares closed at $52.16 yesterday. United Therapeutics' trailing-twelve-month ROE is 24.64%.

Analysts at Jefferies downgraded Nabors Industries (NYSE: NBR) from “hold” to “underperform.” Nabors Industries' shares closed at $14.53 yesterday. Nabors Industries' trailing-twelve-month profit margin is 0.44%.

Keefe Bruyette downgraded Comerica (NYSE: CMA) from “market perform” to “underperform.” Comerica's shares closed at $29.27 yesterday. Comerica's PEG ratio is 0.95.

Latest Ratings for VECO

DateFirmActionFromTo
May 2015BenchmarkInitiates Coverage onBuy
May 2015Canaccord GenuityMaintainsHold
May 2015SusquehannaMaintainsPositive

View More Analyst Ratings for VECO
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (CMA + NBR)

Get Benzinga's Newsletters